Cas:1497-49-0 N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride manufacturer & supplier

We serve Chemical Name:N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride CAS:1497-49-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride

Chemical Name:N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride
CAS.NO:1497-49-0
Synonyms:GLUTACONDIALDEHYDE DIANILE HYDROCHLORIDE;Pentadienedianiline hydrochloride;1,7-diphenyl-1,7-diazahepta-1,3,5-trien hydrochloride;1,5-PENTAMETHINEDIANILIDE-HYDROCHLORIDE;N-(5-Anilino-2,4-pentadienylidene)aniline hydrochloride;N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride;GLUTACONDIALDEHYDE DIANIL HYDROCHLORIDE;EINECS 216-094-3;MFCD00012630;N-[5-anilinopenta-2,4-dienylidene]anilinium chloride;GlutacondialdehydeDianilHCl;Glutaconaldehydedianil Hydrochloride;GLUTACONDIALDEHYDE HCL;N-[5-(phenylamino)-2,4-penta-dienylidene]aniline monohydrochloride;GLUTACONIC ALDEHYDE DIANILIDE HCL;GLUTACONDIANIL HCL
Molecular Formula:C17H17ClN2
Molecular Weight:284.78300
HS Code:

Physical and Chemical Properties:
Melting point:152 °C
Boiling point:402.3ºC at 760 mmHg
Density:0.95g/cm3
Index of Refraction:
PSA:24.39000
Exact Mass:284.10800
LogP:5.44590

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like GLUTACONDIALDEHYDE DIANILE HYDROCHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,GLUTACONDIANIL HCL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,7-diphenyl-1,7-diazahepta-1,3,5-trien hydrochloride Use and application,N-[5-(phenylamino)-2,4-penta-dienylidene]aniline monohydrochloride technical grade,usp/ep/jp grade.


Related News: Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride manufacturer A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride supplier Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride vendor As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory��s officials as they are struggling to contain the coronavirus outbreak. N-[5-(Phenylamino)-2,4-pentadienylidene]aniline monohydrochloride factory Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.